Palvella Therapeutics PVLA Interest Expense
Discontinued — last reported Q4 '25
Interest Expense at other companies
Other financials
Where this comes from
Reported directly by Palvella Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:InterestExpenseDebt.
The official record: Palvella Therapeutics’s 10-K, filed March 31, 2026, on SEC EDGAR. View the filing →
Ask your AI about Palvella Therapeutics's interest expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Palvella Therapeutics's interest expense?
- Palvella Therapeutics (PVLA) reported interest expense of $0 in Q4 2025.
- How has Palvella Therapeutics's interest expense changed year-over-year?
- Palvella Therapeutics's interest expense decreased by 100.0% year-over-year, from $181K to $0.
- What does interest expense mean?
- Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.